Properties
Description
LY2606368 is an CDK kinase inhibitor that disrupts cell division processes. It targets Chk1, Chk1, and Chk2.
Molecular Weight
365.38916
Molecular Formula
C18H19N7O2
Targets
Chk1: 0.9 nM (Ki); Chk1: <1 nM; Chk2: 8 nM
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
LY2606368 can be used to explore its dual inhibition of CHK1 and CHK2, and its implications for cancer treatment.
